Coronary interventions

Clinical outcomes after percutaneous coronary intervention for in-stent chronic total occlusion

EuroIntervention 2020;16:472-479. DOI: 10.4244/EIJ-D-19-00650

Yong-Hoon Yoon
Yong-Hoon Yoon1, MD; Pil Hyung Lee2, MD; Seung-Whan Lee2, MD; Osung Kwon2, MD; Kyusup Lee2, MD; Do-Yoon Kang2, MD; Jung-Min Ahn2, MD; Duk-Woo Park2, MD; Soo-Jin Kang2, MD; Young-Hak Kim2, MD; Cheol Whan Lee2, MD; Seong-Wook Park2, MD; Seung-Jung Park2, MD
1. Division of Cardiology, Chungnam National University Hospital, Chungnam National University School of Medicine, Daejeon, South Korea; 2. Division of Cardiology, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea

Aims: The aim of this study was to compare percutaneous coronary intervention (PCI) outcomes in relation to stent optimisation profiles between in-stent chronic total occlusions (CTOs) and de novo CTOs.

Methods and results: We evaluated 1,516 consecutive patients who underwent PCI for 147 in-stent CTOs (9.3%) and 1,439 de novo CTOs between 2007 and 2018. The primary endpoint was target vessel failure (TVF) consisting of a composite of cardiac death, target vessel-related myocardial infarction, or target vessel revascularisation. The final post-stenting intravascular ultrasound (IVUS) images were analysed. Target lesion complexity reflected by the Japanese CTO score was similar, albeit calcification was more prevalent in de novo CTOs, whereas occlusion length >20 mm was more frequent in in-stent CTOs. The technical success (88.4% vs 87.5%, p=0.84) and in-hospital adverse event (1.4% vs 3.6%, p=0.26) rates were similar between CTO types. Among those who received drug-eluting stents, the five-year TVF (11.0% vs 10.7%, p=0.99) and target vessel revascularisation (4.2% vs 3.7%, p=0.81) rates were similar between groups. Total stent length, minimum stent area (5.4±1.8 vs 5.5±1.8 mm2, p=0.77), and maximal plaque burden of the reference segments were largely comparable between groups.

Conclusions: In-stent CTO PCI with drug-eluting stents optimised by IVUS guidance offers as acceptable long-term clinical results as those achieved in de novo CTOs. 

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

chronic coronary total occlusiondrug-eluting stentin-stent restenosis
Coronary interventionsCTO
Read next article
Outcomes of stent optimisation in intravascular ultrasound-guided interventions for long lesions or chronic total occlusions

Latest news